BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 7 hits Enz. Inhib. hit(s) with Target = 'Ectonucleotide pyrophosphatase/phosphodiesterase family member 2' and Ligand = 'BDBM193117'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Homo sapiens (Human))
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 50n/an/an/an/an/an/a


TBA

Assay Description
TABLE VI: (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using the fluorogenic autotaxin substrate FS-3 as substrate. FS-3 is a doubly l...


Citation and Details

BindingDB Entry DOI: 10.7270/Q241716Z
More data for this
Ligand-Target Pair
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Homo sapiens (Human))
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 50n/an/an/an/an/an/a



GALAPAGOS NV

US Patent




US Patent US10526329 (2020)


BindingDB Entry DOI: 10.7270/Q2Z60RGR
More data for this
Ligand-Target Pair
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Homo sapiens (Human))
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/a8.525



GALAPAGOS NV

US Patent


Assay Description
Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate. 5 μL of a di...


US Patent US9670204 (2017)


BindingDB Entry DOI: 10.7270/Q2W66HZS
More data for this
Ligand-Target Pair
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Homo sapiens (Human))
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



GALAPAGOS NV

US Patent


Assay Description
Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate.5 μL of a dil...


US Patent US10526329 (2020)


BindingDB Entry DOI: 10.7270/Q2Z60RGR
More data for this
Ligand-Target Pair
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Homo sapiens (Human))
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a


TBA

Assay Description
TABLE V: 5 μL of a dilution series of compound, starting from 20 μM highest concentration, 1/5 dilution, is added to the wells. hENPP2 is u...


Citation and Details

BindingDB Entry DOI: 10.7270/Q241716Z
More data for this
Ligand-Target Pair
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Homo sapiens (Human))
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 771n/an/an/an/an/an/a



Galapagos SASU , 102 Avenue Gaston Roussel, 93230 Romainville, France.

Curated by ChEMBL


Assay Description
Inhibition of glycosylated human ATX using LPC 16:0 as substrate after 30 mins by luminescence assay


J Med Chem 60: 7371-7392 (2017)


Article DOI: 10.1021/acs.jmedchem.7b00647
BindingDB Entry DOI: 10.7270/Q2R213VZ
More data for this
Ligand-Target Pair
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2


(Rattus norvegicus)
BDBM193117
PNG
(US10526329, Compound 192 | US11072611, Compound 19...)
Show SMILES CCc1nc2ccc(cn2c1N(C)c1nc(cs1)-c1ccc(F)cc1)N1CCN(Cc2cnc[nH]2)CC1
Show InChI InChI=1S/C27H29FN8S/c1-3-23-26(33(2)27-32-24(17-37-27)19-4-6-20(28)7-5-19)36-16-22(8-9-25(36)31-23)35-12-10-34(11-13-35)15-21-14-29-18-30-21/h4-9,14,16-18H,3,10-13,15H2,1-2H3,(H,29,30)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 4.10E+3n/an/an/an/an/an/a



Galapagos SASU , 102 Avenue Gaston Roussel, 93230 Romainville, France.

Curated by ChEMBL


Assay Description
Inhibition of ATX in rat plasma assessed as reduction in plasma lysophosphatidic acid 18:2 levels after 2 hrs by LC-MS/MS method


J Med Chem 60: 7371-7392 (2017)


Article DOI: 10.1021/acs.jmedchem.7b00647
BindingDB Entry DOI: 10.7270/Q2R213VZ
More data for this
Ligand-Target Pair